FSD Pharma Inc. | WebDisclosure

PRESS RELEASE

published on 02/26/2024 at 14:00, 2 years 4 months ago

FSD Pharma Signs Agreement With Ingenu CRO to Conduct a Clinical Trial To Determine the Safety and Efficacy Effects of its Proprietary Blend Beverage unbuzzd(TM)
FSD Pharma Inc. announced an agreement for a clinical trial to test unbuzzd™ effects on faster alcohol metabolism. The trial aims to confirm the supplement's potential benefits in sobering up from alcohol intoxication

FSD Pharma Inc. Biopharmaceutical Clinical Trial Unbuzzd™ Alcohol Metabolism
BRIEF

published on 02/26/2024 at 14:00, 2 years 4 months ago

FSD Pharma launches a clinical trial to test the effectiveness of unbuzzd™

FSD Pharma Clinical Test Unbuzzd™ Alcohol Metabolism Accelerated Sobriety
BRIEF

published on 02/26/2024 at 14:00, 2 years 4 months ago

FSD Pharma lance un essai clinique pour tester l'efficacité d'unbuzzd™

FSD Pharma Essai Clinique Unbuzzd™ Métabolisme De L'alcool Sobriété Accélérée
PRESS RELEASE

published on 02/17/2024 at 01:10, 2 years 4 months ago

FSD Pharma Announces US ATM Offering
FSD Pharma announces an at-the-market offering agreement with H.C. Wainwright & Co., LLC to sell Class B Shares for up to US$11,154,232. The Company may use proceeds for clinical trials & general corporate purposes

FSD Pharma Biopharmaceutical At-the-market Offering H.C. Wainwright & Co. Class B Shares
PRESS RELEASE

published on 02/06/2024 at 13:00, 2 years 5 months ago

Court of Appeal Dismisses Motion for Leave to Appeal Brought by Dr. Raza Bokhari, FSD Pharma Awards Total Approximately $3 Million
FSD Pharma Inc. announced that the Court of Appeal for Ontario affirmed the Judgment entered by the Superior Court of Justice. The company also filed a Petition to Confirm Arbitration Awards in the United States District Court for the Eastern District of Pennsylvania

FSD Pharma Inc. Court Of Appeal Biopharmaceutical Arbitration Awards Neurodegenerative Disorders
PRESS RELEASE

published on 01/29/2024 at 22:30, 2 years 5 months ago

FSD Pharma Announces Dr. Sanjiv Chopra is elected to FSD Pharma Board of Directors and Corporate Updates
FSD Pharma appoints Dr. Sanjiv Chopra to its board of directors, replaces Nitin Kaushal. Also, the company retains SBS Intl Group LLC, Draper Inc., Carriage House Capital, Corp., IR Agency, Beyond Media, Issuer Direct for various services. FSD focuses on biopharmaceutical assets

FSD Pharma Dr. Sanjiv Chopra Biopharmaceutical SBS Intl Group LLC IR Agency
PRESS RELEASE

published on 01/16/2024 at 13:30, 2 years 5 months ago

Update Provided on GBB Drink Lab, Inc. Litigation and Safety Shot
FSD Pharma Inc., a biopharmaceutical company, provides an update on its litigation with GBB Drink Lab, Inc., denying allegations and moving for discovery. The company remains confident in its legal position and looks forward to vindicating its rights and exposing GBB and its bully tactics.

Biopharmaceutical Company FSD Pharma Inc. Litigation Update GBB Drink Lab Inc. Alcohol Detoxification
PRESS RELEASE

published on 12/23/2023 at 01:45, 2 years 6 months ago

FSD Pharma Files Final Base Shelf Prospectus to Replace Expired Base Shelf Prospectus and Form F-3 Registration Statement with the SEC
PRESS RELEASE

published on 12/05/2023 at 15:00, 2 years 7 months ago

FSD Pharma Inc. Announces Closing of Private Placement
FSD Pharma Inc. announces the closing of private placement and issuance of class A multiple voting shares at $1.90 per share for gross proceeds of $45.60. The proceeds will be used for general working capital purposes

Private Placement FSD Pharma Inc. Financial News Investment Class A Multiple Voting Shares
PRESS RELEASE

published on 11/30/2023 at 14:30, 2 years 7 months ago

FSD Pharma Inc. and Celly Nutrition Corp. Announce Completion of Plan of Arrangement
FSD Pharma Inc. and Celly Nutrition Corp. announce completion of Plan of Arrangement including distribution of Celly Nu Shares and New FSD Pharma Securities to FSD Pharma securityholders

FSD Pharma Inc. Plan Of Arrangement Celly Nutrition Corp. Celly Nu Shares New FSD Pharma Securities

Published on 07/14/2026 at 01:45, 6 hours 13 minutes ago

Arctic Fox Lithium Approved for Trading on the OTCQB Venture Market and Announces DTC Eligibility
Published on 07/14/2026 at 00:01, 7 hours 57 minutes ago

Captor Capital Announces Delay in its Annual Filings
Published on 07/13/2026 at 23:10, 8 hours 48 minutes ago

Galaxy Ventures Inc. Announces Director Resignation
Published on 07/13/2026 at 21:35, 10 hours 23 minutes ago

ATHA Energy Announces Corporate Activities Update
Published on 07/13/2026 at 20:00, 11 hours 58 minutes ago

IBC Announces Share-Based Compensation to Directors

View all ACCESSWIRE

Published on 07/14/2026 at 07:47, 10 minutes ago

EQS-Adhoc: DATA MODUL Aktiengesellschaft Produktion und Vertrieb von elektronischen Systemen:
Published on 07/14/2026 at 07:30, 27 minutes ago

REINET INVESTMENTS S.C.A. SHARE BUYBACK PROGRAMME – UPDATE 14 July 2026
Published on 07/14/2026 at 07:30, 28 minutes ago

SFC Energy AG secures CAD 3.1 million follow-up order from North American mobile surveillance solutions provider
Published on 07/14/2026 at 07:30, 28 minutes ago

Bastei Lübbe with higher revenues in tandem with reduced profitability in a difficult market environment
Published on 07/14/2026 at 07:00, 57 minutes ago

The Swiss are confident about the future despite acknowledging some areas of concern

View all EQS

Published on 07/13/2026 at 18:00, 13 hours 58 minutes ago

CP Icade - Icade reprend 100% de la propriété de la Tour Eqho à la Défense
Published on 07/13/2026 at 18:00, 13 hours 58 minutes ago

PR Icade - Icade regains full ownership of the Eqho Tower in La Défense
Published on 07/13/2026 at 18:00, 13 hours 58 minutes ago

THERMADOR GROUPE : 2026 half-year turnover
Published on 07/13/2026 at 18:00, 13 hours 58 minutes ago

THERMADOR GROUPE : publication du chiffre d'affaires semestriel 2026
Published on 07/13/2026 at 17:45, 14 hours 13 minutes ago

Weekly share buyback

View all LES ECHOS COMFI WIRE

News